Oxytocin dose effects during cesarean sectio

Not Applicable

Completed

• Conditions: Control of bleeding during cesarean section; Pregnancy and Childbirth; Cesarean section

• Registration Number: ISRCTN28030442
• Lead Sponsor: Federal state budget educational institution higher education «Amur State Medical Academy» of the Ministry of Health of the Russian Federation.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2018-11-30
• Study Start: 2019-10-03
• Last Update Posted: 29 October 2019

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 45

Inclusion Criteria

1. Full-term singleton pregnancy
2. Elective cesarean section
3. Age of 15 to 25 years inclusive
4. Body mass index (BMI) below 25 kg/m²
5. Pregnancy and labor parity - 1

Exclusion Criteria

1. Severe extragenital diseases
2. Preeclampsia and eclampsia

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Intraoperative ST segment depression measured using intraoperative ECG monitoring (II standard lead), ST segment depression (mm); ST segment status was analyzed using BeneView T6 patient monitor (Mindray, China).<br> 2. Intraoperative hypotension: Arterial hypotension was noted as systolic blood pressure below 80 mm Hg, lasted less than 5 min. and was controlled with IV microfluidic infusion of noradrenalin solution with the rate of 0.03 µg/kg/min.<br>

Secondary Outcome Measures

Name	Time	Method
Intraoperative blood loss was determined using indirect visual method by a team of MD’s, which included: a surgeon (obstetrician-gynecologist, highest Qualification Grade), an assistant surgeon and an anesthesiologist-intensivist (highest Qualification Grade).